Sphingosine kinase type 1 inhibitors
1 Assignment
0 Petitions
Reexamination
Accused Products
Abstract
Provided are novel compositions and analogs which are useful in a number of applications, indications and diseases, as well as for monitoring pharmakinetics and patient management. These compounds and analogs are applicable to treating tumors of the central nervous system, e.g., glioblastoma (GBM).
28 Citations
12 Claims
- 1. A compound selected from
Specification